Pipeline: Presbyopia, night vision disturbance up next for Vyluma

Video

Presbyopia and night vision disturbance will follow myopia as a clinical focus for Vyluma. Navneet Puri, PhD, the company’s founder, chairman, and CEO, shares what is next.

Recent Videos
Dr. Mark Bullimore investigates myopia in an omnibus model at AAOpt 2024
Pediatric optometrist Dr. Magdela Stec speaks about myopia management at EyeCon 2024
Dr Adam Wenick at EyeCon 2024
Brianna Rhue, OD, FAAO, FSLS, talks myopia management at Vision Expo West 2024
Mandy Sallach of Johnson & Johnson speaks on initiatives to combat pediatric myopia
Drs Tracy Schroeder Swartz and Clark Chang overview their keratoconus talk at Optometry's Meeting
David A. Berntsen, OD, PhD, FAAO, outlines his presentation on the BLINK 2 study presented at the 2024 ARVO meeting
© 2024 MJH Life Sciences

All rights reserved.